Related Experiment Video
Updated: Dec 7, 2025

11:14
Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
9.5K
The first case of HIV-2 in Scotland
S J Shepherd1, C Sykes2, C Jackson1
1West of Scotland Specialist Virology Centre, Level 5 New Lister Building, Glasgow Royal Infirmary, 10-16 Alexandra Parade, G31 2ER, UK.
Access Microbiology
|September 25, 2020
Summary
Human Immunodeficiency Virus type 2 (HIV-2) is rare but presents unique management challenges. This case study details the complex, long-term treatment adjustments required for an HIV-2 patient in Scotland.
Area of Science:
- Virology
- Infectious Diseases
- Clinical Medicine
Background:
- HIV-1 is globally prevalent, while HIV-2 is rarer and geographically restricted, primarily to West Africa.
- Scotland predominantly diagnoses HIV-1, with HIV-2 being uncommon.
- The West of Scotland Specialist Virology Centre (WoSSVC) identified Scotland's first HIV-2 case in 2013.
Observation:
- HIV-2 exhibits distinct characteristics from HIV-1, including structural protein differences, transmissibility, latency, antiviral resistance, and treatment monitoring.
- The diagnosed patient required multiple treatment modifications over five years.
- These changes were necessitated by adverse side effects and high pill burden.
Findings:
- Managing HIV-2 infection involves unique complexities compared to HIV-1.
- Long-term patient care requires adaptive treatment strategies to address individual responses and tolerability.
- This case underscores the need for specialized approaches in HIV-2 management.
Implications:
- Clinical guidelines may need refinement to better address HIV-2 specificities.
- Further research into HIV-2 pathogenesis and treatment optimization is warranted.
- Healthcare providers should be aware of the distinct clinical and management considerations for HIV-2 patients.
Related Concept Videos
Sexually Transmitted Infections
679
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
679
Immunodeficiency Diseases
1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.8K
Rous Sarcoma Virus (RSV) and Cancer
5.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.9K
Pulmonary Tuberculosis II
1.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.0K

